Lilly Seeks Court Action Against Compounded Copies of Its Popular Weight-Loss Medications

Indianapolis-based pharmaceutical giant Eli Lilly and Co. has requested to join a lawsuit targeting manufacturers of compounded versions of its popular weight-loss drugs. The company alleges that these compounded versions might pose safety risks and infringe on its intellectual property rights. This legal move comes as the U.S. weight-loss drug market experiences significant growth, driven by increasing awareness and consumer demand for effective obesity treatments. The lawsuit, originally filed by the U.S. Department of Justice, seeks to halt the production and distribution of unauthorized compounded versions of drugs similar to Lilly’s FDA-approved offerings, including Mounjaro … Read more

Judge Orders Martin Shkreli to Surrender Copies of Exclusive Wu-Tang Clan Album Amid Legal Battle with Crypto Collective

NEW YORK — Martin Shkreli, the controversial former pharmaceutical executive infamous for drastically raising the price of a vital medication, has been directed by a federal court to surrender all copies of the unique Wu-Tang Clan album “Once Upon a Time in Shaolin” by the end of the week. The court’s mandate comes as part of a broader legal challenge involving a breach of agreement over the album’s exclusivity. Judge Pamela K. Chen of Brooklyn ruled that Shkreli must disclose the whereabouts of all copies of the album, sometimes described as the world’s most exclusive … Read more